Cardiac arrest & resuscitation

Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest

Crit CarePublished Retrospective cohort study

Authors' conclusion

GFAP and tau are promising biomarkers for neuroprognostication, with the highest predictive performance at 48 h after OHCA, but not superior to NFL. The predictive ability of GFAP may be sufficiently high for clinical use at 12 h after cardiac arrest.

Study context

Population
Patients admitted to intensive care unit (ICU) after OHCA or in-hospital cardiac arrest (IHCA), three hospitals in Sweden, 2014–2018328 OHCA, 100 IHCA
Participants
428 patients
Exposure
Plasma glial fibrillary acidic protein (GFAP) and total-tau as predictors of poor neurological outcome, compared with neurofilament light (NFL) and neuron-specific enolase (NSE)
Outcome
Poor neurological outcome (Cerebral Performance Category 3-5); prognostic performance by AUC
Follow-up
2-6 months after cardiac arrest
Methodological detailsmulticentre, observational
  • Multicentre
  • Observational

Main finding

As reported in the abstract

Prediction of poor neurological outcome (AUC) at ICU admission, 12 h and 48 h
GroupAUC, OHCA, ICU admission (95% CI 0.70-0.82)AUC, OHCA, 12 h (95% CI 0.81-0.90)AUC, OHCA, 48 h (95% CI 0.87-0.96)AUC, IHCA, ICU admission (95% CI 0.66-0.87)AUC, IHCA, 12 h (95% CI 0.74-0.92)AUC, IHCA, 48 h (95% CI 0.71-0.95)AUC, OHCA, ICU admission (95% CI 0.66-0.79)AUC, OHCA, 12 h (95% CI 0.69-0.81)AUC, OHCA, 48 h (95% CI 0.89-0.96)AUC, IHCA, ICU admission (95% CI 0.49-0.74)AUC, IHCA, 12 h (95% CI 0.56-0.79)AUC, IHCA, 48 h (95% CI 0.65-0.90)
GFAP0.760.860.910.770.830.83— not stated in the abstract— not stated in the abstract— not stated in the abstract— not stated in the abstract— not stated in the abstract— not stated in the abstract
Tau— not stated in the abstract— not stated in the abstract— not stated in the abstract— not stated in the abstract— not stated in the abstract— not stated in the abstract0.720.750.930.610.680.77

AUC, OHCA, ICU admission (95% CI 0.70-0.82)

GFAP0.76
Tau— not stated in the abstract

AUC, OHCA, 12 h (95% CI 0.81-0.90)

GFAP0.86
Tau— not stated in the abstract

AUC, OHCA, 48 h (95% CI 0.87-0.96)

GFAP0.91
Tau— not stated in the abstract

AUC, IHCA, ICU admission (95% CI 0.66-0.87)

GFAP0.77
Tau— not stated in the abstract

AUC, IHCA, 12 h (95% CI 0.74-0.92)

GFAP0.83
Tau— not stated in the abstract

AUC, IHCA, 48 h (95% CI 0.71-0.95)

GFAP0.83
Tau— not stated in the abstract

AUC, OHCA, ICU admission (95% CI 0.66-0.79)

GFAP— not stated in the abstract
Tau0.72

AUC, OHCA, 12 h (95% CI 0.69-0.81)

GFAP— not stated in the abstract
Tau0.75

AUC, OHCA, 48 h (95% CI 0.89-0.96)

GFAP— not stated in the abstract
Tau0.93

AUC, IHCA, ICU admission (95% CI 0.49-0.74)

GFAP— not stated in the abstract
Tau0.61

AUC, IHCA, 12 h (95% CI 0.56-0.79)

GFAP— not stated in the abstract
Tau0.68

AUC, IHCA, 48 h (95% CI 0.65-0.90)

GFAP— not stated in the abstract
Tau0.77

— not stated in the abstract

Observational data: associations, not effects.

Further findings

Adding change in biomarker levels between time points

Did not improve predictive accuracy vs the last time point

GFAP and tau vs NSE at 48 h (subset of patients)

GFAP at 12 h and 48 h and tau at 48 h offered similar predictive value as NSE at 48 h after both OHCA and IHCA

NFL vs GFAP and tau

NFL predictive performance similar or superior to GFAP and tau at all time points after OHCA and IHCA

Original publication

Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest. Crit Care. Published 9 April 2024. doi:10.1186/s13054-024-04889-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.